Carbidopa | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Carbidopa
EDQM

Evonik

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Carbidopa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 20 USDMF, 17 CEP/COS, 8 JDMF, 1 EU WC, 7 KDMF, 14 NDC API, 18 Listed Suppliers, $ API Reference Price

39 API Suppliers
20 USDMF
17 CEP/COS
8 JDMF
1 EU WC
7 KDMF
14 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

343 FDF Dossiers, 118 FDA Orange Book, 167 Europe, 17 Canada, 12 South Africa, 29 Listed Dossiers

343 FDF Dossiers
118 FDA Orange Book
167 Europe
17 Canada
12 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET;ORAL - 25MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 3 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 47 Direct Compression, 46 Disintegrants & Superdisintegrants, 39 Controlled & Modified Release, 32 Thickeners and Stabilizers, 31 Solubilizers, 31 Granulation, 25 Taste Masking, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 22 Parenteral, 21 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 13 Topical, 9 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

92 Fillers, Diluents & Binders
65 Coating Systems & Additives
47 Direct Compression
46 Disintegrants & Superdisintegrants
39 Controlled & Modified Release
32 Thickeners and Stabilizers
31 Solubilizers
31 Granulation
25 Taste Masking
23 Lubricants & Glidants
23 Film Formers & Plasticizers
22 Parenteral
21 Chewable & Orodispersible Aids
20 Co-Processed Excipients
13 Topical
9 API Stability Enhancers
8 Emulsifying Agents
7 Rheology Modifiers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 70 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
70 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 150 Finished Drug Prices, 11 Annual Reports

9 US Medicaid Prescriptions
150 Finished Drug Prices
11 Annual Reports

MARKET PLACE

10 APIs, 9 FDF Dossiers

10 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

105 US Patents, 4 US Exclusivities

105 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 1 JP, 7 Others

3 EDQM
2 USP
1 JP
7 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 360 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1C0460000

02 1Y0001713

03 1Y0001716

filter CAS Number Reset all filters

3 All

01 238821-49-7

02 1N/A

filter Reference Standard Reset all filters

3 All

01 1Carbidopa

02 1Carbidopa for system suitability

03 1Carbidopa impurity mixture

Product Main Page

01

EDQM, Council of Europe

Carbidopa impurity mixture

2024 ACI Convention

Not Confirmed

EDQM, Council of Europe

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Carbidopa impurity mixture

CAS Number : N/A

Quantity Per Vial : 0.008 mg

Sale Unit : 1

Order Code : Y0001716

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Carbidopa for system suitability

2024 ACI Convention

Not Confirmed

EDQM, Council of Europe

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Carbidopa for system suitability

CAS Number : 38821-49-7

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001713

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Carbidopa

2024 ACI Convention

Not Confirmed

EDQM, Council of Europe

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CAS Number : 38821-49-7

Quantity Per Vial : 50 mg

Sale Unit : 1

Order Code : C0460000

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?